March 5, 2009
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Ashwin Dandekar, Vice President, Brand Management Practice, will present a session at EyeforPharma’s Oncology Summit USA on March 30 and 31, 2009 at the Boston Park Plaza Hotel in Boston, Massachusetts. Dr. Dandekar will also present a workshop at EyeForPharma’s Oncology Market Access Europe Conference, scheduled for April 22 and 23, 2009 at the Zürich Marriott Hotel in Zürich, Switzerland.
Dr. Dandekar’s presentation at EyeforPharma’s Oncology Summit USA is scheduled for 3:30 pm March 30 as a part of “Session 3: Market Access and Early Commercialization”. His presentation, titled “The Building Blocks of Successful Oncology Commercialization,” will examine the four building blocks for maximizing the commercial value of new oncology products. Specifically, the presentation will focus on developing long-term vision for products in tandem with comprehensive market-entry strategies, creating winning labels and development programs, assessing and developing markets, and building the company’s infrastructure and resources to put into action commercialization strategies.
At EyeforPharma’s Oncology Market Access Europe Conference, Dr. Dandekar will present a workshop at 2:00 pm on April 20. His workshop, also titled “The Building Blocks of Successful Oncology Commercialization,” will similarly examine the essential elements of maximizing commercial value for oncology products, but will focus on commercialization in European markets.
“The oncology market is undoubtedly complicated as products themselves are complex, market competition is fierce, and there are many strategic and organizational challenges that result from the specialized nature of the products,” Dr. Dandekar said. “Consequently, oncology product commercialization can be highly complex.”
Dr. Dandekar leverages his training as a physician and his consulting experience to help clients across the pharmaceutical, biotech, and healthcare industries. He has particular expertise in combining clinical knowledge with sound marketing skills to assist clients with new product strategy, market analysis, and product positioning. Prior to consulting, Dr. Dandekar worked as a research analyst at the University Hospitals of Cleveland, and as a physician and administrative director at Dandekar Hospital in Bombay, India. Dr. Dandekar received his MBA from the Weatherhead School of Management at Case Western Reserve University and an MBBS from MGM Medical School and Hospital, Bombay University.
For more information on EyeforPharma’s Oncology Summit USA, please visit http://www.eyeforpharma.com/oncologyusa09.
For more information on EyeforPharma’s Oncology Market Access Europe Conference, please visit http://www.eyeforpharma.com/oncology09/venue.
Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company’s online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.
About the Brand Management Practice at Campbell Alliance